Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Blood Neoplasia|September 15, 2025
Clarithromycin, ixazomib, pomalidomide, dexamethasone for relapsed/refractory myeloma: survival and correlative analysisAaron S Rosenberg, Emanual Maverakis, Caitlin Costello, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 5, 2026
Choosing Wisely in First Relapse of Multiple Myeloma: Expert Insights on Treatment SelectionSamer Al Hadidi, Caitlin Costello, Luciano J Costa, et al.
The Journal of Biological Chemistry|November 2, 2006
Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipDSteven Johnson, Pietro Roversi, Marianela Espina, et al.
Cell Stem Cell|January 21, 2021
Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruptionPhoebe K Mondala, Ashni A Vora, Tianyuan Zhou, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 2, 2023
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myelomaCarolyn Rath, Claude Yoo, Halle Cheplowitz, et al.
Hematology (Amsterdam, Netherlands)|July 8, 2022
Extracorporeal photopheresis for the treatment of chronic graft versus host diseaseEmin Kansu, David Ward, Amber P Sanchez, et al.
Nature Communications|December 6, 2017
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myelomaElisa Lazzari, Phoebe K Mondala, Nathaniel Delos Santos, et al.
Blood Advances|June 24, 2025
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abataceptDivya Koura, Kaitlyn Dykes, Aaron Goodman, et al.
Pageof 7